Target intelligence / Profile preview

CLDN10 antisense RNA 1 (CLDN10-AS1)

Target
CLDN10-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

CLDN10 antisense RNA 1 (CLDN10-AS1) is a long non-coding RNA gene found on chromosome 13. It functions primarily as an antisense transcript opposite the Claudin 10 (CLDN10) protein-coding gene. CLDN10-AS1 is implicated in regulatory processes such as cell migration, modulation of receptor and protein kinase activities, and tight junction maintenance. Recent studies highlight its role in pathological mechanisms such as extracellular vesicle-mediated injury in vascular endothelial cells, particularly under conditions of oxidative stress. While associated with some disease states and cellular pathways, CLDN10-AS1 is not a direct therapeutic target, nor are there existing drugs known to interact with it. Its role as a biomarker or its safety profile have not been established, but ongoing research suggests it may contribute to mechanisms linked to vascular injury and possibly other disease contexts.

Other names
CLDN10-AS1CLDN10 antisense RNA 1 (non-protein coding)
02

Mechanism of action

Not applicable, as it is not a direct target for drugs, but it may have regulatory roles affecting cellular pathways and disease states

03

Biological functions

Cell migrationRegulation of transmembrane receptor functionRegulation of protein kinase activityPotential modulation of tight junction pathways (in proximity to Claudin 10 gene)
04

Disease associations

Vascular endothelial cell injury (e.g., in oxidized LDL-induced damage)Potential association with diseases via GWAS, but details are limited

Beyond the preview

Go deeper on CLDN10 antisense RNA 1 (CLDN10-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLDN10 antisense RNA 1 (CLDN10-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call